484 related articles for article (PubMed ID: 28297025)
1. Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.
Ashok AH; Mizuno Y; Volkow ND; Howes OD
JAMA Psychiatry; 2017 May; 74(5):511-519. PubMed ID: 28297025
[TBL] [Abstract][Full Text] [Related]
2. Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.
Proebstl L; Kamp F; Manz K; Krause D; Adorjan K; Pogarell O; Koller G; Soyka M; Falkai P; Kambeitz J
Eur Psychiatry; 2019 Jun; 59():15-24. PubMed ID: 30981746
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
4. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
[TBL] [Abstract][Full Text] [Related]
5. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.
Ballard ME; Dean AC; Mandelkern MA; London ED
PLoS One; 2015; 10(12):e0143510. PubMed ID: 26657223
[TBL] [Abstract][Full Text] [Related]
6. Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.
London ED
Adv Pharmacol; 2016; 76():67-84. PubMed ID: 27288074
[TBL] [Abstract][Full Text] [Related]
7. Heightened Dopaminergic Response to Amphetamine at the D
Boileau I; Payer D; Rusjan PM; Houle S; Tong J; McCluskey T; Wilson AA; Kish SJ
Neuropsychopharmacology; 2016 Dec; 41(13):2994-3002. PubMed ID: 27353309
[TBL] [Abstract][Full Text] [Related]
8. Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.
Ashok AH; Mizuno Y; Howes OD
Psychopharmacology (Berl); 2019 Apr; 236(4):1119-1129. PubMed ID: 30887059
[TBL] [Abstract][Full Text] [Related]
9. Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies.
Kamp F; Proebstl L; Penzel N; Adorjan K; Ilankovic A; Pogarell O; Koller G; Soyka M; Falkai P; Koutsouleris N; Kambeitz J
Neuropsychopharmacology; 2019 Mar; 44(4):660-667. PubMed ID: 30188512
[TBL] [Abstract][Full Text] [Related]
10. Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.
Boileau I; McCluskey T; Tong J; Furukawa Y; Houle S; Kish SJ
Neuropsychopharmacology; 2016 Mar; 41(4):1179-87. PubMed ID: 26321315
[TBL] [Abstract][Full Text] [Related]
11. The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Howes OD; Kambeitz J; Kim E; Stahl D; Slifstein M; Abi-Dargham A; Kapur S
Arch Gen Psychiatry; 2012 Aug; 69(8):776-86. PubMed ID: 22474070
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED
Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300
[TBL] [Abstract][Full Text] [Related]
13. In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.
Narendran R; Lopresti BJ; Martinez D; Mason NS; Himes M; May MA; Daley DC; Price JC; Mathis CA; Frankle WG
Am J Psychiatry; 2012 Jan; 169(1):55-63. PubMed ID: 22193525
[TBL] [Abstract][Full Text] [Related]
14. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
[TBL] [Abstract][Full Text] [Related]
15. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.
Lee B; London ED; Poldrack RA; Farahi J; Nacca A; Monterosso JR; Mumford JA; Bokarius AV; Dahlbom M; Mukherjee J; Bilder RM; Brody AL; Mandelkern MA
J Neurosci; 2009 Nov; 29(47):14734-40. PubMed ID: 19940168
[TBL] [Abstract][Full Text] [Related]
17. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.
Robertson CL; Ishibashi K; Chudzynski J; Mooney LJ; Rawson RA; Dolezal BA; Cooper CB; Brown AK; Mandelkern MA; London ED
Neuropsychopharmacology; 2016 May; 41(6):1629-36. PubMed ID: 26503310
[TBL] [Abstract][Full Text] [Related]
18. Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature.
Narendran R; Martinez D
Synapse; 2008 Nov; 62(11):851-69. PubMed ID: 18720516
[TBL] [Abstract][Full Text] [Related]
19. A history of ethanol drinking increases locomotor stimulation and blunts enhancement of dendritic dopamine transmission by methamphetamine.
Tschumi CW; Daszkowski AW; Sharpe AL; Trzeciak M; Beckstead MJ
Addict Biol; 2020 Jul; 25(4):e12763. PubMed ID: 31062485
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.
Gill KE; Pierre PJ; Daunais J; Bennett AJ; Martelle S; Gage HD; Swanson JM; Nader MA; Porrino LJ
Neuropsychopharmacology; 2012 Nov; 37(12):2555-65. PubMed ID: 22805600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
